Risk factor
Good trading liquidity
Profitability factor
Strong margins and returns
About
Chengdu Kanghua Biological Products Co., Ltd. engages in the research, development, production, sale, and technical service of biological products in China. It offers group ACYW135 meningococcal polysaccharide vaccines; and freeze-dried human diploid cell rabies vaccines. The company also develops seasonal influenza vaccines without preservatives, which completed phase III clinical trials; and human H5N1 influenza vaccine...
Company Valuation
From both historical and forecast perspectives, the stock is overpriced compared to similar stocks. In particular, the stock is overpriced on P/E, of fair value on EV/EBI
Target Price
The average target price of 300841.SZ is 64 and suggests 8% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to d
Buy
Sell